Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma.

scientific article published in June 2002

Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/CNCR.10594
P698PubMed publication ID12115353
P5875ResearchGate publication ID11264050

P50authorOscar ArrietaQ61114456
Roberto Garcia-NavarreteQ74455643
P2093author name stringEsperanza Garcia
Julio Sotelo
Patricia Guevara
Daniel Rembao
Rodolfo Ondarza
P2860cites workInteraction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesisQ28295920
Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomasQ33778706
HGF: a multifunctional growth factor controlling cell scattering.Q33821093
Hepatocyte growth factor/scatter factor-induced intracellular signallingQ33863966
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factorQ35961109
Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factorQ37408097
Expression of c-met is a strong independent prognostic factor in breast carcinomaQ38472256
Hepatocyte growth factor: a multifunctional cytokineQ40580427
Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells.Q40864192
Angiogenesis in malignant gliomasQ40961541
Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factorQ41077052
Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growthQ41103718
The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cellsQ41563732
Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growthQ41596252
Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a reviewQ41697538
Tumor angiogenesis--a new therapeutic target in gliomas.Q41712744
Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitroQ42803690
Peritumoral brain edema in meningiomas--influence of vascular supply on its developmentQ44750202
Serum concentration of hepatocyte growth factor in patients with metastatic breast cancerQ44886234
Targeting angiogenesis: genetic intervention which strikes at the weak link of tumorigenesisQ45858145
Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cellsQ47680471
Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cellsQ47712891
Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissuesQ48172929
Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeabilityQ48182286
In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factorQ48218884
Immunohistochemical examination of c-Met protein expression in astrocytic tumorsQ48484004
Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical studyQ48571377
Growth factor profiles of human gliomas. Do non-tumour cells contribute to tumour growth in glioma?Q48584137
Depressed T lymphocyte function in brain tumor patients: Monocytes as suppressor cellsQ48848496
Necrosis as a prognostic factor in glioblastoma multiformeQ49057512
Expression of scatter factor in human bladder carcinoma.Q52511260
Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.Q53408477
Different point mutations in the met oncogene elicit distinct biological properties.Q53413979
Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.Q55477127
Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans.Q55477950
Vascular endothelial growth/permeability factor expression in human glioma specimens: correlation with vasogenic brain edema and tumor-associated cysts.Q55480421
The trends in incidence of primary brain tumors in the population of Rochester, Minnesota.Q55481350
Fractionated radiation therapy in the treatment of intracranial meningiomas: Local control, functional efficacy, and tolerance in 91 patientsQ72054560
Efficacy of conventional radiotherapy for recurrent meningiomaQ73065346
Hepatocyte growth factor/scatter factor in the eyeQ73072251
Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapyQ73201919
Brain tumorsQ73377286
Brain tumors in Mexico: characteristics and prognosis of glioblastomaQ73538695
MIB-1 staining index of pediatric meningiomasQ73676134
Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failureQ73908703
HGF/scatter factor selectively promotes cell invasion by increasing integrin avidityQ74121592
Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinomaQ74128408
Recurrence of meningiomasQ74240040
Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: a study of 60 tumorsQ74301873
Biological role of HGF/MET pathway in renal cell carcinomaQ74450114
Protamine inhibits angiogenesis and growth of C6 rat glioma; a synergistic effect when combined with carmustineQ74591595
P433issue12
P407language of work or nameEnglishQ1860
P304page(s)3210-3218
P577publication date2002-06-01
P1433published inCancerQ326041
P1476titleHepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma
P478volume94